Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Melanoma 35Lung Neoplasms 12Neoplasm Metastasis 10Carcinoma, Renal Cell 10Carcinoma, Non-Small-Cell Lung 10Lymphoma, T-Cell, Cutaneous 6Breast Neoplasms 6Brain Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Colorectal Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Merkel Cell 5Carcinoma, Hepatocellular 5Uveal Melanoma 4Thyroid Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Mycosis Fungoides 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4Carcinoma, Basal Cell 4Waldenstrom Macroglobulinemia 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, T-Cell 3

Interventions

cobimetinib 1Vemurafenib 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erdheim-Chester Disease × Magnetic Resonance Spectroscopy × Dermatologic × Clear all
NCT06712810 2025-10-10

Q702 for the Treatment of Patients With Hematologic Malignancies

Mayo Clinic

Phase 1 Recruiting
46 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasmSarcoma

Blastic Plasmacytoid Dendritic Cell Neoplasm, Histiocytosis, Langerhans-Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelomonocytic, Chronic, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Erdheim-Chester Disease, Dendritic Cell Sarcoma, Interdigitating, Histiocytic Sarcoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡